127 related articles for article (PubMed ID: 20407410)
41. [Does a rational therapeutic plan exist for nosocomial bacteremia caused by Pseudomonas aeruginosa?].
Torné J; García Flores A; Tomás S; Serrano R
Med Clin (Barc); 1987 Oct; 89(13):572. PubMed ID: 3121961
[No Abstract] [Full Text] [Related]
42. Antimicrobial salvage therapy for native valve MRSA endocarditis.
Cortes J; Sagar AS; Lee Y; Sandhu U; Boka K
J Antimicrob Chemother; 2017 Jun; 72(6):1841-1842. PubMed ID: 28333236
[No Abstract] [Full Text] [Related]
43. [Unusual clinical aspects of infections due to Pseudomonas aeruginosa].
Veber B
Ann Fr Anesth Reanim; 2003 Jun; 22(6):539-43. PubMed ID: 12893381
[No Abstract] [Full Text] [Related]
44. [Antibiotic resistance of some Pseudomonas aeruginosa isolates].
Matinca D; Vancea D; Boboş C; Serban O
Bacteriol Virusol Parazitol Epidemiol; 2003; 48(2-3):157-61. PubMed ID: 15341333
[No Abstract] [Full Text] [Related]
45. In vivo impact of the MexAB-OprM efflux system on beta-lactam efficacy in an experimental model of Pseudomonas aeruginosa infection.
Boutoille D; Jacqueline C; Le Mabecque V; Potel G; Caillon J
Int J Antimicrob Agents; 2009 May; 33(5):417-20. PubMed ID: 19157801
[TBL] [Abstract][Full Text] [Related]
46. Pseudomonas endocarditis.
Reyes MP; Lerner AM
JAMA; 1979 Apr; 241(15):1576. PubMed ID: 107332
[No Abstract] [Full Text] [Related]
47. Long-term oral ciprofloxacin: experience in the treatment of incurable infective endocarditis.
Daikos GL; Kathpalia SB; Lolans VT; Jackson GG; Fosslien E
Am J Med; 1988 Apr; 84(4):786-90. PubMed ID: 3135746
[TBL] [Abstract][Full Text] [Related]
48. Impact of AmpC overexpression on outcomes of patients with Pseudomonas aeruginosa bacteremia.
Tam VH; Chang KT; Schilling AN; LaRocco MT; Genty LO; Garey KW
Diagn Microbiol Infect Dis; 2009 Mar; 63(3):279-85. PubMed ID: 19135330
[TBL] [Abstract][Full Text] [Related]
49. Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality.
Tumbarello M; Repetto E; Trecarichi EM; Bernardini C; De Pascale G; Parisini A; Rossi M; Molinari MP; Spanu T; Viscoli C; Cauda R; Bassetti M
Epidemiol Infect; 2011 Nov; 139(11):1740-9. PubMed ID: 21226988
[TBL] [Abstract][Full Text] [Related]
50. Treatment and outcome of Pseudomonas aeruginosa bacteraemia: an antibiotic pharmacodynamic analysis.
Zelenitsky SA; Harding GK; Sun S; Ubhi K; Ariano RE
J Antimicrob Chemother; 2003 Oct; 52(4):668-74. PubMed ID: 12951354
[TBL] [Abstract][Full Text] [Related]
51. Investigation of the clinical breakpoints of piperacillin-tazobactam against infections caused by Pseudomonas aeruginosa.
Yamagishi Y; Terada M; Ohki E; Miura Y; Umemura T; Mikamo H
J Infect Chemother; 2012 Feb; 18(1):127-9. PubMed ID: 21814800
[TBL] [Abstract][Full Text] [Related]
52. A Pseudomonas aeruginosa isolate producing the GES-5 extended-spectrum beta-lactamase.
Wang C; Cai P; Chang D; Mi Z
J Antimicrob Chemother; 2006 Jun; 57(6):1261-2. PubMed ID: 16617065
[No Abstract] [Full Text] [Related]
53. Nosocomial meningitis due to Pseudomonas aeruginosa in children.
Kralinsky K; Svetlansky I; Kovacicova G; Filka J; Huttova M; Krcmery V
J Chemother; 2000 Dec; 12(6):538-9. PubMed ID: 11154042
[No Abstract] [Full Text] [Related]
54. Peripheral venous catheter and bloodstream infection caused by Pseudomonas aeruginosa after a contaminated preoperative shower.
Romano S; Bourdier A; Parer S; Masnou A; Burgel L; Raczka F; Lamy B; Jumas-Bilak E; Lotthé A
Infect Control Hosp Epidemiol; 2013 May; 34(5):544-6. PubMed ID: 23571380
[No Abstract] [Full Text] [Related]
55. Therapy of experimental Pseudomonas endocarditis with high-dose amikacin and ticarcillin.
Choi C; Bayer AS; Fujita NK; Lam K; Guze LB; Yoshikawa TT
Chemotherapy; 1983; 29(4):303-12. PubMed ID: 6872621
[TBL] [Abstract][Full Text] [Related]
56. Antimicrobial combination treatment including ciprofloxacin decreased the mortality rate of Pseudomonas aeruginosa bacteraemia: a retrospective cohort study.
Paulsson M; Granrot A; Ahl J; Tham J; Resman F; Riesbeck K; Månsson F
Eur J Clin Microbiol Infect Dis; 2017 Jul; 36(7):1187-1196. PubMed ID: 28110415
[TBL] [Abstract][Full Text] [Related]
57. Pseudomonas aeruginosa in chronic suppurative otitis media: sensitivity spectrum against various antibiotics in Karachi.
Mansoor T; Musani MA; Khalid G; Kamal M
J Ayub Med Coll Abbottabad; 2009; 21(2):120-3. PubMed ID: 20524487
[TBL] [Abstract][Full Text] [Related]
58. Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.
Kim HS; Park BK; Kim SK; Han SB; Lee JW; Lee DG; Chung NG; Cho B; Jeong DC; Kang JH
BMC Infect Dis; 2017 Jul; 17(1):500. PubMed ID: 28716109
[TBL] [Abstract][Full Text] [Related]
59. Selection of resistance by piperacillin during Pseudomonas aeruginosa endocarditis.
Letendre ED; Mantha R; Turgeon PL
J Antimicrob Chemother; 1988 Oct; 22(4):557-62. PubMed ID: 3144526
[TBL] [Abstract][Full Text] [Related]
60. Pseudomonas endocarditis: cure with carbenicillin and polymyxin B.
Diaz CR; Fossieck BE; Parker RH
South Med J; 1977 Jul; 70(7):869-71. PubMed ID: 195349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
